Mylan (MYL): From Top to Bottom

Mylan N.V. (MYL) is an interesting player in the Healthcare space, with a focus on Drugs – Generic. The stock has been active on the tape, currently trading at $40.08, up from yesterday’s close by 2.30%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Mylan N.V. (MYL) currently trades with a market capitalization of $19.75 Billion. That value represents a market adjusting for revenues that have been falling by -1.29 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $1.99 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.97 on a per share basis this quarter. Perhaps, that suggests something about why 0.63% of the outstanding share supply is held by institutional investors.



Technical Analysis

As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Mylan N.V. recorded a 52-week high of $47.82. It is now trading 7.74% off that level. The stock is trading $39.82 its 50-day moving average by -0.26%. The stock carved out a 52-week low down at $29.39.

In recent action, Mylan N.V. (MYL) has made a move of -1.79% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 15.08, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 3.74% with $483.36 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of MYL.

SHARE
Previous articleTaking a Fresh Look at Akamai Technologies, Inc. (AKAM)
Next articleDrilling Down Into The Charles Schwab Corporation (SCHW)